| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $43.7M | +15.3% |
| SG&A Expense | $12.0M | -7.9% |
| Operating Income | -$55.8M | -9.4% |
| Pre-tax Income | -$47.5M | +0.3% |
| Net Income | -$47.5M | +1.0% |
| EPS (Basic) | -$0.60 | +3.2% |
| EPS (Diluted) | -$0.60 | +3.2% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $151.0M | +1.3% |
| Total Assets | $154.4M | +1.1% |
| Total Liabilities | $12.5M | +22.7% |
| Stockholders' Equity | $141.9M | -0.4% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.8M | -14.6% |
| Financing Cash Flow | $29.7M | +39.3% |